Calculated based on number of publications stored in Pure and citations from Scopus
20142023

Research activity per year

Network

J. J. Swen

  • Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
  • Leiden University
  • Department of Clinical Pharmacy and Toxicology
  • Dutch SUTOX consortium

External person

H. J. Guchelaar

  • Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
  • Leiden University
  • University of Groningen
  • Department of Clinical Pharmacy and Toxicology
  • Dutch SUTOX consortium

External person

Hans Gelderblom

  • Leiden University
  • Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
  • Leiden UMC
  • Dutch SUTOX consortium

External person

D. Castellano

  • Hospital Universitario 12 de Octubre
  • Spanish Oncology Genitourinary Group

External person

Cristina Rodríguez-Antona

  • Instituto de Salud Carlos III
  • Centro Nacional de Investiga-ciones Oncológicas

External person

J. García-Donas

  • Spanish Oncology Genitourinary Group
  • Clara Campal Comprehensive Cancer Center
  • HM Hospitales—Centro Integral Oncológico HM Clara Campal

External person

Ron H.J. Mathijssen

  • Erasmus University Rotterdam
  • Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
  • Dutch SUTOX consortium
  • Center for Personalised Cancer Treatment

External person

E. Boven

  • Dutch Working Group Focusing on Genotype-related Sunitinib-induced Toxicity (SUTOX Consortium)
  • VU University Medical Center
  • Vrije Universiteit Amsterdam
  • Dutch SUTOX consortium

External person

B. I. Rini

  • Cleveland Clinic Foundation

External person

Max Roessler

  • CESAR Central European Society for Anticancer Drug Research-EWIV
  • CESAR Central Office (CCO)

External person

Egbert Oosterwijk

  • Radboud University Nijmegen

External person

Lambertus A.L.M. Kiemeney

  • Radboud University Nijmegen
  • Netherlands Association of Comprehensive Cancer Centres
  • Netherlands Cancer Institute
  • Comprehensive Cancer Centers
  • Erasmus University Rotterdam
  • Comprehensive Cancer Center the Netherlands
  • Comprehensive Cancer Centers-Amsterdam South Netherlands East Netherlands Middle Netherlands Norther
  • deCODE Genetics

External person

Marius T. Radu

  • Carol Davila University of Medicine and Pharmacy

External person

Ulrich Jaehde

  • University of Bonn

External person

Kerstin Junker

  • Saarland University

External person

Sita H. Vermeulen

  • Radboud University Nijmegen

External person

Tim Eisen

  • Cambridge University Hospitals NHS Foundation Trust

External person

Loes F.M. van der Zanden

  • Radboud University Nijmegen

External person

Stefan Böhringer

  • Leiden University

External person

Xiaoyan Liu

  • Leiden University
  • Shandong University
  • Dutch SUTOX consortium

External person

Achim Fritsch

  • University of Bonn

External person

Valentin Ambert

  • Carol Davila University of Medicine and Pharmacy

External person

Jake S.F. Maurits

  • Radboud University Nijmegen

External person

Rob Ruijtenbeek

  • PamGene International B.V.

External person

R. W.F. van Leeuwen

  • Erasmus University Rotterdam

External person

Bastiaan Nuijen

  • Netherlands Cancer Institute
  • Slotervaart Hospital
  • Antoni van Leeuwenhoek Hospital

External person

Anna Martinez-Cardus

  • Bellvitge Biomedical Research Institute

External person

Lidwien M. Hanff

  • Princess Máxima Center for Pediatric Oncology
  • Erasmus University Rotterdam

External person

Anne Cambon-Thomsen

  • Université Fédérale Toulouse Midi-Pyrénées
  • Université de Toulouse, UPS
  • Institut national de la santé et de la recherche médicale

External person

Anne Warren

  • Cambridge University Hospitals NHS Foundation Trust

External person

Rosa Guarch Troyas

  • Hospital Virgen del Camino

External person

Stefan Sleijfer

  • Erasmus University Rotterdam
  • Center for Personalised Cancer Treatment
  • Center for Personalized Cancer Treatment

External person

Christina Hulsbergen-Van De Kaa

  • Radboud University Nijmegen
  • Laboratory of Pathology East Netherlands (LABPON)

External person

D. Schindele

  • Otto von Guericke University Magdeburg

External person

T. Gauler

  • University of Duisburg-Essen

External person

L. Bergmann

  • Goethe University Frankfurt

External person

Gisli Masson

  • deCODE Genetics

External person

Lodewyk F.A. Wessels

  • Cancer Genomics Center (CGC)
  • Netherlands Cancer Institute
  • Oncode Institute
  • Delft University of Technology
  • Antoni van Leeuwenhoek Hospital

External person

Angelique D. Huitema

  • Princess Máxima Center for Pediatric Oncology

External person

Annemarie M.L. Peek

  • VU University Medical Center
  • University of Groningen
  • Princess Máxima Center for Pediatric Oncology

External person

K. Mross

  • Tumor Biology Center Freiburg

External person

Huixin Yu

  • Netherlands Cancer Institute
  • Antoni van Leeuwenhoek Hospital
  • Slotervaart Hospital

External person

María Apellániz-Ruiz

  • Instituto de Salud Carlos III

External person

M. Kinzig

  • IBMP - Institute for Biomedical and Pharmaceutical Research

External person

Lianne M. Haveman

  • University of Amsterdam
  • Princess Máxima Center for Pediatric Oncology

External person

Arna Oskarsdottir

  • deCODE Genetics

External person

Carlota Mestres-Gonzalvo

  • Maastricht University Medical Center+

External person

T. Rafnar

  • deCODE Genetics

External person

Tsuneharu Miki

  • Kyoto Prefectural University of Medicine

External person

Juan M. Roldán

  • Instituto de Salud Carlos III

External person

F. Kanefendt

  • University of Bonn

External person

D. Houtsma

  • Haga Ziekenhuis

External person

Kristin Alexiusdottir

  • Landspitali University Hospital

External person

Jesus Garcia Donas

  • Medical Oncology

External person

Karel K.M. Koudijs

  • Leiden University

External person

F. Sörgel

  • IBMP - Institute for Biomedical and Pharmaceutical Research

External person

C. Stelzer

  • IBMP - Institute for Biomedical and Pharmaceutical Research

External person

A. Belaustegui

  • Hospital de Cruces

External person

Howard Gurney

  • University of Sydney
  • Macquarie University

External person

Bram Rutgers

  • University Medical Center Groningen

External person

Jacqueline S.L. Kloth

  • Erasmus University Rotterdam

External person

Ron H.N. Van Schaik

  • Erasmus University Rotterdam
  • Department of Clinical Chemistry

External person

Heinz Josef Klümpen

  • University of Amsterdam
  • Amsterdam UMC

External person

Anne Y. Warren

  • Cambridge University Hospitals NHS Foundation Trust
  • University of Cambridge

External person

Ron H.J. Mathijssen

  • Erasmus University Rotterdam

External person

Asgerdur Sverrisdottir

  • Landspitali University Hospital

External person

Judith Potjewijd

  • Maastricht University

External person

Arndt Hartmann

  • Friedrich-Alexander University Erlangen-Nürnberg

External person

Frederike K. Engels

  • Princess Máxima Center for Pediatric Oncology

External person

Martijn P. Lolkema

  • Utrecht University
  • Erasmus University Rotterdam
  • Center for Personalized Cancer Treatment
  • Center for Personalised Cancer Treatment

External person

Kari Stefansson

  • deCODE Genetics
  • University of Iceland
  • Landspitali University Hospital

External person

Ruben Malmberg

  • Erasmus University Rotterdam

External person

B. Moritz

  • CESAR Central Office (CCO)
  • CESAR Central European Society for Anticancer Drug Research-EWIV

External person

S. Hauser

  • University of Bonn

External person

Jeannette Oosterwijk-Wakka

  • Radboud University Nijmegen

External person

Moes Djar

  • Leiden University

External person

Niels A.D. Guchelaar

  • Erasmus University Rotterdam

External person

Fumiya Hongo

  • Kyoto Prefectural University of Medicine

External person

Neeltje Steeghs

  • Netherlands Cancer Institute
  • Utrecht University
  • Antoni van Leeuwenhoek Hospital
  • The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital
  • Center for Personalised Cancer Treatment

External person